Aspirin for the prevention of cardiovascular events in patients with peripheral artery disease

Published on Nov 4, 2009in Praxis Journal of Philosophy
· DOI :10.1024/1661-8157.98.22.1315
Spaar A1
Estimated H-index: 1
📖 Papers frequently viewed together
3 Citations
Cited By9
#1Connie N. Hess (University of Colorado Denver)H-Index: 21
#2William R. Hiatt (University of Colorado Denver)H-Index: 96
15 CitationsSource
#1F. GeraldH-Index: 2
#2R. FowkesH-Index: 2
Last. Gordon D. MurrayH-Index: 112
view all 10 authors...
2 Citations
#1Ben J. Connolly (McMaster University)H-Index: 2
#2Lesly A. PearceH-Index: 52
Last. Robert G. Hart (McMaster University)H-Index: 104
view all 5 authors...
Background Subdural hematomas are an important bleeding complication of antithrombotic therapies. We sought to characterize the risk of subdural hematoma associated with antiplatelet therapy. Methods Trials were gathered from the Cochrane Central Register of Controlled Trials and from recent meta-analyses of trials regarding antiplatelet therapy for the primary prevention of stroke. Randomized trials published since 1980 comparing antiplatelet therapy with placebo or control and reporting subdur...
31 CitationsSource
#1Annie M. Bérard (University of Bordeaux)H-Index: 9
#2Aurélie Bedel (University of Bordeaux)H-Index: 14
Last. Joël Constans (University of Bordeaux)H-Index: 30
view all 22 authors...
BACKGROUND: This study aimed to determine the prevalence of genetic and environmental vascular risk factors in non diabetic patients with premature peripheral arterial disease, either peripheral arterial occlusive disease or thromboangiitis obliterans, the two main entities of peripheral arterial disease, and to established whether some of them are specifically associated with one or another of the premature peripheral arterial disease subgroups. METHODS AND RESULTS: This study included 113 non ...
30 CitationsSource
The management of renal artery stenosis remains controversial with randomized trials suggesting that revascularization is no better than medical therapy. Thus all patients with atheromatous renovascular disease should be treated with medical therapy. However optimal therapy has not been clearly defined by atheromatous renovascular disease trials; despite this, there are data to support the use of several pharmacologic agents among this group of patients. Such a regimen should include an angioten...
3 CitationsSource
#2Henri BounameauxH-Index: 85
Last. Alexander G.G. Turpie (Hamilton General Hospital)H-Index: 110
view all 8 authors...
BACKGROUND: Terutroban is a selective prostaglandin endoperoxide (TP) receptor antagonist with antithrombotic, antivasoconstrictive and antiatherosclerotic properties and is currently in development for long-term cardiovascular secondary prevention. OBJECTIVES: TAIPAD is an international, double-blind, randomized controlled study comparing the effects of five dosages of oral terutroban vs. aspirin and placebo on platelet aggregation in peripheral arterial disease (PAD) patients. PATIENTS/METHODS...
26 CitationsSource
#1F. Gerald R. Fowkes (Edin.: University of Edinburgh)H-Index: 46
#2Jacqueline F Price (Edin.: University of Edinburgh)H-Index: 27
Last. Gordon D. Murray (Edin.: University of Edinburgh)H-Index: 112
view all 10 authors...
Context A low ankle brachial index (ABI) indicates atherosclerosis and an increased risk of cardiovascular and cerebrovascular events. Screening for a low ABI can identify an asymptomatic higher risk group potentially amenable to preventive treatments. Objective To determine the effectiveness of aspirin in preventing events in people with a low ABI identified on screening the general population. Design, Setting, and Participants The Aspirin for Asymptomatic Atherosclerosis trial was an intention...
453 CitationsSource
#1F. GeraldH-Index: 2
#2R. FowkesH-Index: 2
Last. Marlene C. W. StewartH-Index: 20
view all 4 authors...
#1Lars NorgrenH-Index: 27
#2David BergqvistH-Index: 93
Last. Håkan PärssonH-Index: 6
view all 3 authors...